The Genomics Law Report (GLR) posted an interesting blog about the emergence of mobile health (mHealth) and the role many believe it could play in improving the quality and delivery of health care. It discusses how the mHealth regulatory landscape is still in its early stages of formation and has many key players and components that will help guide its development. It then outlines many of the players, such as the FDA, FCC, FTC, and HHS, and the various ways in which each organization might help shape the future of mHealth.
The story also makes mention of the FTC’s “privacy by design” recommendation for mobile applications, which is undoubtedly a critical component to protecting patients’ privacy as more innovative technologies and apps hit the marketplace. However, aside from ensuring that strong privacy controls are built into the apps up front, it will also be important to make sure patients have other important privacy protections, like control over their sensitive health information, no matter the medium used to collect and share it.
To read the full blog from GLR, click here.